| Literature DB >> 35647171 |
Seung Jung Yu1, Jae Hyuk Heo1, Eun Jeong Choi1, Jong Hyuk Kim2, Hong Sub Lee3, Sun Young Kim4, Jae Hoon Lim2.
Abstract
BACKGROUND: The role of multidetector computed tomography (MDCT) in patients with acute infectious colitis is still unclear. AIM: To examine the usefulness of MDCT in distinguishing the etiology of acute infectious colitis.Entities:
Keywords: Bacterial infections; Colitis; Differential diagnosis; Multidetector computed tomography; Viral infections
Year: 2022 PMID: 35647171 PMCID: PMC9100710 DOI: 10.12998/wjcc.v10.i12.3686
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.534
Figure 1Serosal involvement. Enhanced multidetector computed tomography axial image in portal venous phase shows wall thickening with submucosal edema and pericolic fat stranding (arrow) in descending colon.
Figure 2Comb sign. Coronal reconstructed image shows perivascular inflammatory infiltration (arrow) that forms linear densities on the mesenteric side of the affected segments of left small bowel. Fluid distended bowel is also noted.
Figure 3Accordion sign. Contrast-enhanced multidetector computed tomography coronal reconstructed image (A) and axial image (B) show hyperemic enhancing mucosa stretched over markedly thickened submucosal folds with irregular mucosal contour with polypoid protrusions.
Figure 4Enlarged lymph node. Enhanced multidetector computed tomography axial image in portal venous phase shows enlarged lymph node (arrow, short axis diameter is measured as 12 mm) with strong enhancement adjacent to ascending colon.
Figure 5Empty colon sign. Coronal reconstructed image shows complete emptiness (no gas, fluid, or feces) of the transverse colon. Marked wall thickening with mucosal hyperenhancement is also seen.
Figure 6Flow diagram showing study design and patient selection.
Acute colitis prevalence and summary statistics of baseline characteristics by COI
|
|
|
|
|
|
|
| Prevalence (%) | 16 | 84 | |||
| Season (%) | Spring | 24 | 35 | 22 | 0.001 |
| Summer | 39 | 15 | 44 | ||
| Autumn | 22 | 23 | 22 | ||
| Winter | 15 | 28 | 13 | ||
| Sex (%) | Male | 45 | 45 | 45 | 1.000 |
| DM (%) | Yes | 14 | 15 | 13 | 0.801 |
| CVD (%) | Yes | 11 | 10 | 11 | 1.000 |
| MALIG (%) | Yes | 3 | 3 | 3 | 1.000 |
| Age (mean ± SD) | 45.1 ± 20.9 | 41.8 ± 21.5 | 45.7 ± 20.8 | 0.271 | |
| Height (mean ± SD) | 165.4 ± 9.6 | 166.5 ± 9.4 | 165.2 ± 9.6 | 0.487 | |
| Weight (mean ± SD) | 65.1 ± 14.6 | 67.8 ± 17.4 | 64.6 ± 14.1 | 0.271 | |
| BMI (mean ± SD) | 23.7 ± 4.1 | 24.1 ± 4.6 | 23.6 ± 4.1 | 0.492 |
Fisher's exact test for season, sex, diabetes mellitus, cardiovascular disease;, and history of malignancy, and ANOVA test otherwise.
DM: Diabetes mellitus; CVD: Cardiovascular disease; MALIG: History of malignancy; BMI: Body mass index.
Acute colitis prevalence for 11 computed tomography parameters by COI
|
|
|
|
|
|
|
| Prevalence (%) | 16 | 84 | |||
| Wall thickening (%) | Yes | 82 | 40 | 90 | 0.000 |
| Submucosal edema (%) | Yes | 82 | 30 | 93 | 0.000 |
| Mucosal enhancement (%) | Yes | 79 | 28 | 89 | 0.000 |
| Serosal involvement (%) | Yes | 39 | 5 | 46 | 0.000 |
| Empty colon sign (%) | Yes | 43 | 13 | 49 | 0.000 |
| Small bowel involvement (%) | Yes | 38 | 30 | 40 | 0.288 |
| Comb sign (%) | Yes | 13 | 3 | 15 | 0.036 |
| Continuous distribution (%) | Yes | 75 | 25 | 85 | 0.000 |
| Accordion sign (%) | Yes | 15 | 3 | 17 | 0.014 |
| Mucosal thickening (%) | Yes | 57 | 5 | 67 | 0.000 |
| Lymph node enlargement (%) | Yes | 18 | 8 | 21 | 0.072 |
Fisher's exact test.
Recategorized to binary values of normal vs non-normal.
Sensitivity and specificity of the 11 computed tomography parameters for predicting viral or bacterial acute colitis prevalence
|
|
|
| ||||||
|
|
|
|
|
|
|
|
| |
| Wall thickening | 40.0 | 10.3 | 8.0 | 46.7 | 89.7 | 60.0 | 92.0 | 53.3 |
| Submucosal edema | 30.0 | 7.4 | 6.0 | 34.9 | 92.6 | 70.0 | 94.0 | 65.1 |
| Mucosal enhancement | 27.5 | 11.3 | 5.7 | 44.2 | 88.7 | 72.5 | 94.3 | 55.8 |
| Serosal involvement | 5.0 | 53.9 | 2.1 | 74.3 | 46.1 | 95.0 | 97.9 | 25.7 |
| Empty colon sign | 12.5 | 51.0 | 4.8 | 74.8 | 49.0 | 87.5 | 95.2 | 25.2 |
| Small bowel involvement | 30.0 | 60.3 | 12.9 | 81.5 | 39.7 | 70.0 | 87.1 | 18.5 |
| Comb sign | 2.5 | 85.3 | 3.2 | 81.7 | 14.7 | 97.5 | 96.8 | 18.3 |
| Continuous distribution | 25.0 | 15.2 | 5.5 | 50.8 | 84.8 | 75.0 | 94.5 | 49.2 |
| Accordion sign | 2.5 | 82.8 | 2.8 | 81.3 | 17.2 | 97.5 | 97.2 | 18.8 |
| Mucosal thickening | 5.0 | 33.3 | 1.4 | 64.2 | 66.7 | 95.0 | 98.6 | 35.8 |
| Lymph node enlargement | 7.5 | 79.4 | 6.7 | 81.4 | 20.6 | 92.5 | 93.3 | 18.6 |
Recategorized to binary values of normal vs non-normal.
CT: Computed tomography; Se: Sensitivity; Sp: Specificity; PPV: Positive predictive value; NPV: Negative predictive value.
Odds ratios of viral or bacterial acute colitis prevalence for each of the 11 computed tomography parameters
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| Wall thickening | 0.07 | 0.03 | 0.17 | 0.000 | 13.60 | 5.80 | 31.88 | 0.000 |
| Submucosal edema | 0.03 | 0.01 | 0.07 | 0.000 | 36.08 | 13.54 | 96.13 | 0.000 |
| Mucosal enhancement | 0.04 | 0.02 | 0.11 | 0.000 | 22.55 | 9.28 | 54.81 | 0.000 |
| Serosal involvement | 0.07 | 0.02 | 0.30 | 0.000 | 14.50 | 3.33 | 63.23 | 0.000 |
| Empty colon sign | 0.15 | 0.05 | 0.41 | 0.000 | 6.68 | 2.44 | 18.32 | 0.000 |
| Small bowel involvement | 0.69 | 0.32 | 1.50 | 0.353 | 1.44 | 0.67 | 3.13 | 0.353 |
| Comb sign | 0.19 | 0.02 | 1.50 | 0.115 | 5.25 | 0.67 | 41.32 | 0.115 |
| Continuous distribution | 0.04 | 0.02 | 0.11 | 0.000 | 24.09 | 9.38 | 61.90 | 0.000 |
| Accordion sign | 0.11 | 0.01 | 0.89 | 0.038 | 9.02 | 1.12 | 72.35 | 0.038 |
| Mucosal thickening | 0.02 | 0.00 | 0.10 | 0.000 | 46.41 | 10.38 | 207.51 | 0.000 |
| Lymph node enlargement | 0.23 | 0.06 | 0.82 | 0.023 | 4.39 | 1.22 | 15.72 | 0.023 |
Recategorized to binary values of normal vs non-normal.
Adjusted for age, season, sex, diabetes, cardiovascular diseases, and cancer history. CT: Computed tomography.
Sensitivity and specificity of the four combined computed tomography parameters1 for predicting viral or bacterial acute colitis prevalence
|
|
|
| ||||||
|
|
|
|
|
|
|
|
| |
| Summer and all four | 2.50 | 74.02 | 1.85 | 79.47 | 25.98 | 97.50 | 98.15 | 20.53 |
| Summer and at least one | 7.50 | 58.33 | 3.41 | 76.28 | 41.67 | 92.50 | 96.59 | 23.72 |
| Winter and all four | 2.50 | 90.69 | 5.00 | 82.59 | 9.31 | 97.50 | 95.00 | 17.41 |
| Winter and at least one | 15.00 | 87.75 | 19.35 | 84.04 | 12.25 | 85.00 | 80.65 | 15.96 |
Submucosal edema, mucosal enhancement, continuous distribution, and mucosal thickening.
CT: Computed tomography; Se: Sensitivity; Sp: Specificity; PPV: Positive predictive value; NPV: Negative predictive value.
Odds ratios of viral or bacterial acute colitis prevalence for each of the four combined computed tomography parameters1
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| Summer and all four | 0.13 | 0.01 | 1.16 | 0.07 | 7.75 | 0.86 | 69.93 | 0.07 |
| Summer and at least one | 0.04 | 0.01 | 0.28 | 0.00 | 24.95 | 3.59 | 173.43 | 0.00 |
| Winter and all four | 0.04 | 0.00 | 0.35 | 0.00 | 26.90 | 2.82 | 256.26 | 0.00 |
| Winter and at least one | 0.04 | 0.00 | 0.40 | 0.01 | 28.51 | 2.48 | 327.72 | 0.01 |
Submucosal edema, mucosal enhancement, continuous distribution, mucosal thickening. Adjusted for age, season, sex, diabetes, cardiovascular diseases, and cancer history.
CT: Computed tomography.